Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Infection and Chemotherapy
Published in: Journal of Infection and Chemotherapy 6/2010

01-12-2010 | Case Report

A case of urinary tract infection caused by Kluyvera ascorbata in an infant: case report and review of the literature

Authors: Atsushi Isozaki, Kentaro Shirai, Sho Mimura, Masaki Takahashi, Wakana Furushima, Yutaka Kawano

Published in: Journal of Infection and Chemotherapy | Issue 6/2010

Login to get access

Abstract

We experienced a case of urinary tract infection in a 3-month-old child caused by Kluyvera ascorbata. The authors report the case and review the literature regarding Kluyvera urinary tract infection exclusively in children. Kluyvera infection, which had been extremely rare, has increasingly been reported, including urinary tract infection. A prompt identification of Kluyvera species in clinical infections is important. Recognition of its disease-producing potential and the subsequent initiation of effective antimicrobial coverage are essential for appropriate management in the pediatric population.
Literature
1.
Kluyver AJ, van Niel CB. Prospects for natural system of classification of bacteria. Zentralbl Bakteruol Parasitenkd Infektkrankh Hyg Abt II. 1936;95:369–403.
2.
Asai T, Okumura S, Tsumoda T. On a new genus, Kluyvera. Proc Jpn Acad. 1956;32:488–93.
3.
Farmer JJ 3rd, Davis BR, Hickman-Brenner FW, McWhorter A, Huntley-Carter GP, Asbury MA, et al. Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol. 1985;21:46–76.PubMed
4.
Müller HE, Brenner DJ, Fanning GR, Grimont PA, Kämpfer P. Emended description of Buttiauxella agrestis with recognition of six new species of Buttiauxella and new species of Kluyvera: Buttiauxella ferragutiae sp. nov., Buttiauxella gaviniae sp. nov., Buttiauxella brennerae sp. nov., Buttiauxella izardi sp. nov., Buttiauxella noakiae sp. nov., Buttiauxella warmboldiae sp. nov., Kluyvera cochlea sp. nov., and Kluyvera georgiana sp. nov. Int J Syst Bacteriol. 1996;46:50–63.PubMedCrossRef
5.
Carter JE, Evans TN. Clinically significant Kluyvera infections: a report of seven cases. Am J Clin Pathol. 2005;123:334–8.PubMedCrossRef
6.
Carter JE, Laurini JA, Mizell KN. Kluyvera infection in the pediatric population. Pediatr Infect Dis J. 2008;27:839–41.PubMedCrossRef
7.
Tristram DA, Forbes BA. Kluyvera: a case report of urinary tract infection and sepsis. Pediatr Infect Dis J. 1988;7:297–8.PubMedCrossRef
8.
Dollberg S, Gandacu A, Klar A. Acute pyelonephritis due to a Kluyvera species in a child. Eur J Clin Microbiol Infect Dis. 1990;9:281–3.PubMedCrossRef
9.
Yogev R, Kozlowski S. Peritonitis due to Klutvera ascorbata: case report and review. Rev Infect Dis. 1990;12:399–402.PubMed
10.
Ortega Calvo M, Delgado Zamora R, Fernández Arance P, Elgorriaga Guillén LJ, Del Valle Vázquez L, Gutiérrez Caracuel J. Kluyvera cryocrescens: positive urine culture in a young girl with persistent proteinuria. Acta Urol Esp. 1999;23:528–31.
11.
Sarria JC, Vidal AM, Kimbrough RC 3rd. Infections caused by Kluyvera species in humans. Clin Infect Dis. 2001;33:e69–74.PubMedCrossRef
12.
Narchi H. Kluyvera urinary tract infection: case report and review of the literature. Pediatr Infect Dis J. 2005;24:570–2.PubMedCrossRef
13.
Ruffini E, Pace F, Carlucci M, De Conciliis E, Staffolani P, Carlucci A. Urinary tract infection caused by Kluyvera ascorbata in a child: case report and review of the Kluyvera infections in children. Minerva Pediatr. 2008;60:1451–4.PubMed
Metadata
Title
A case of urinary tract infection caused by Kluyvera ascorbata in an infant: case report and review of the literature
Authors
Atsushi Isozaki
Kentaro Shirai
Sho Mimura
Masaki Takahashi
Wakana Furushima
Yutaka Kawano
Publication date
01-12-2010
Publisher
Springer Japan
Published in
Journal of Infection and Chemotherapy / Issue 6/2010
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-010-0067-3

Other articles of this Issue 6/2010

Journal of Infection and Chemotherapy 6/2010 Go to the issue

Original Article

Results of a multicenter survey of diagnosis and treatment for bacterial meningitis in Japan

Original Article

A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections

Case Report

Relapsing Legionella pneumophila cellulitis: a case report and review of the literature

Announcement

Electronic submission will be available from January 2011 with the online system Editorial Manager®

Original Article

Complement-mediated bacteriolysis after binding of specific antibodies to drug-resistant Pseudomonas aeruginosa: morphological changes observed by using a field emission scanning electron microscope

Original Article

Methicillin resistant Staphylococcus aureus in a Japanese community hospital: 5-year experience
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits